
Keywords: ACA, anti-centromere antibodies; ANA, anti-nuclear antibodies; CI, confidence interval; DLCO, diffusing capacity for carbon monoxide; dSSc, diffuse systemic sclerosis; FVC, forced vital capacity; Ig, immunoglobulin; ILD, interstitial lung disease; lSSc, l